|
Monday 8th April 2024 |
Text too small? |
Heartland announces indicative regulatory approval of Challenger Bank acquisition, and NZ$210m equity raise
Heartland Group Holdings Limited (Heartland) (NZX/ASX: HGH) is pleased to announce that it has received indicative regulatory approvals from the Australian Prudential Regulation Authority (APRA) and the Reserve Bank of New Zealand (RBNZ) for Heartland Bank Limited’s acquisition of Challenger Bank Limited from Challenger Limited (ASX: CGF).
Heartland also announces a NZ$210 million equity raise, comprising an NZ$105 million underwritten institutional placement (Placement) and a NZ$105 million underwritten 1 for 6.85 accelerated non-renounceable entitlement offer (Entitlement Offer).
APRA and RBNZ’s final regulatory approvals are conditional on the successful completion of the Placement and Entitlement Offer.
Included in this announcement is:
1. Offer Announcement
2. Offer Document
3. Investor Presentation
4. NZX Corporate Action Notice
5. Cleansing Notice
ENDS
No comments yet
AGL - Accordant Group Limited announces CEO retirement
VCT - Results of annual shareholders' meeting
HGH - Heartland acknowledges TSB Section 95 Notice
TEM - Transaction in Own Shares
SKO - Serko announces CFO Transition
September 25th Morning Report
CCC - Cooks Coffee Company Appoints New Group Marketing Director
AIR - Air NZ 2026 Annual Shareholders' Meeting Materials
CVT - Annual Meeting, Director Nomination & Shareholder Proposal
TEM - Transaction in Own Shares